NSCLC Therapy Management For Optimal Outcomes



Topic: Cancer.

Destination: Projects that will be considered for Pfizer support will focus on development of an algorithm or tool to guide the optimal treatment and support of patients with ALK or ROS1 re-arranged NSCLC.

Budget: Up to 150,000$.

Duration: Not Indicated.

Estàs interessat?

Omple el següent formulari per rebre més informació: